Table 5 Distributions of latencies of... | American Society of Hematology

Table 5

Distributions of latencies of patients with t-AML stratified by MDM2 genotype

Genotype	No. of patients	Latency, mo		P
Genotype	No. of patients	Median	IQR	P
UC patients with t-AML				.063
TT	31	65	45-125
TG	33	72	25-105
GG	13	32	22-63
Total	77	63	34-114
UK patients with t-AML				.94
TT	24	71	21-149
TG	28	71	28-129
GG	7	70	38-122
Total	59	70	27-139
Combined patients with t-AML				.21
TT	55	65	35-139
TG	61	72	27-119
GG	20	44	29-115
Total	136	64	31-124

Genotype	No. of patients	Latency, mo		P
Genotype	No. of patients	Median	IQR	P
UC patients with t-AML				.063
TT	31	65	45-125
TG	33	72	25-105
GG	13	32	22-63
Total	77	63	34-114
UK patients with t-AML				.94
TT	24	71	21-149
TG	28	71	28-129
GG	7	70	38-122
Total	59	70	27-139
Combined patients with t-AML				.21
TT	55	65	35-139
TG	61	72	27-119
GG	20	44	29-115
Total	136	64	31-124

IQR indicates interquartile range.